Abstract
The interaction of lifestyle, socioeconomic status, genetic factors, and treatment with antipsychotic medications likely accounts for the high risk of metabolic syndrome, diabetes, heart disease, and premature mortality in people with serious mental illness. Given the high risk of developing diabetes and cardiovascular disease in persons with serious mental illness, psychiatrists who treat these individuals need to ensure they are familiar with these risks, monitor metabolic parameters in their patients, and educate their patients (and caregivers) about the risks and how to prevent them.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 109-125 |
| Number of pages | 17 |
| Journal | Psychiatric Clinics of North America |
| Volume | 34 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 1 2011 |
Keywords
- Antipsychotic medication
- Lifestyle management
- Mental illness
- Metabolic syndrome
ASJC Scopus subject areas
- Psychiatry and Mental health
Fingerprint Dive into the research topics of 'Prevention of Metabolic Syndrome in Serious Mental Illness'. Together they form a unique fingerprint.
Cite this
Ganguli, R., & Strassnig, M. (2011). Prevention of Metabolic Syndrome in Serious Mental Illness. Psychiatric Clinics of North America, 34(1), 109-125. https://doi.org/10.1016/j.psc.2010.11.004